Question 1

Who owns RARE?

Accepted Answer

ULTRAGENYX PHARMACEUTICAL IN (RARE) is held by 151 institutional investors that disclose positions via SEC 13F filings. The largest disclosed holder is BlackRock, Inc. as of Q2 2026.

Question 2

Are institutions buying or selling RARE?

Accepted Answer

In Q2 2026, 81 institutions opened or increased positions in ULTRAGENYX PHARMACEUTICAL IN while 76 reduced or exited — a net buying quarter.

Question 3

What is the Smart Money Verdict on RARE?

Accepted Answer

HoldingsIntel scores ULTRAGENYX PHARMACEUTICAL IN across four independent sources (institutional 13F activity, insider trades, activist filings, and congressional trades) — with 4 of the 4 carrying data for RARE. In Q2 2026, the institutional leg showed net inflows: 81 buying versus 76 selling.

Question 4

How many hedge funds hold RARE?

Accepted Answer

151 institutional investors report holding ULTRAGENYX PHARMACEUTICAL IN (RARE) as of Q2 2026, based on SEC 13F filings.

Question 5

Is institutional money flowing into RARE?

Accepted Answer

As of Q2 2026, tracked institutions in ULTRAGENYX PHARMACEUTICAL IN show 81 buyers versus 76 sellers — net inflows.

Question 6

Are Congress members and hedge funds both buying RARE?

Accepted Answer

Yes — in the latest quarter, 1 members of Congress and 81 institutional investors bought ULTRAGENYX PHARMACEUTICAL IN. HoldingsIntel cross-checks STOCK Act disclosures against 13F filings to surface these overlaps.

	Action
BlackRock, Inc.	Increased	10.7M(+46.0%)	$355.7M	0.0%	-65.23%	42
RTW INVESTMENTS, LP	Increased	7.8M(+113.7%)	$260.3M	2.2%	-63.52%	85
VPVANGUARD PORTFOLIO MANAGEMENT LLC	Increased	6.8M(+26.1%)	$226.7M	0.0%	-46.46%	38
AQR CAPITAL MANAGEMENT LLC	Increased	6.6M(+43.3%)	$214.1M	0.1%	-51.56%	41
STATE STREET CORP	Increased	6.2M(+22.6%)	$205.6M	0.0%	-64.14%	37
VAVANGUARD CAPITAL MANAGEMENT LLC	Increased	4.3M(+2.5%)	$143.5M	0.0%	-41.52%	31
TWO SIGMA INVESTMENTS, LP	Increased	3.6M(+64.2%)	$120.9M	0.1%	-54.59%	44
SANDS CAPITAL MANAGEMENT, LLC	Decreased	3.2M(-1.8%)	$105.5M	0.4%	-71.22%	0
JACOBS LEVY EQUITY MANAGEMENT, INC	Increased	2.9M(+105.4%)	$98.2M	0.4%	-59.58%	58
FRONTIER CAPITAL MANAGEMENT CO LLC	Increased	2.8M(+30.0%)	$95.1M	0.9%	-55.17%	53
GEODE CAPITAL MANAGEMENT, LLC	Increased	2.6M(+39.4%)	$86.1M	0.0%	-71.03%	39
DED. E. Shaw & Co., Inc.	Increased	1.7M(+37.2%)	$57.8M	0.0%	-52.95%	39
AGADAGE CAPITAL PARTNERS GP, L.L.C.	Increased	1.6M(+229.2%)	$52.8M	0.1%	-61.00%	47
MORGAN STANLEY	Decreased	1.3M(-11.7%)	$44.2M	0.0%	-56.89%	0
WELLINGTON MANAGEMENT GROUP LLP	Decreased	1.3M(-52.6%)	$41.8M	0.0%	-66.69%	0
VOLORIDGE INVESTMENT MANAGEMENT, LLC	Decreased	1.2M(-13.0%)	$41.5M	0.2%	-47.62%	0
BANK OF AMERICA CORP /DE/	Increased	1.1M(+9.7%)	$38.3M	0.0%	-59.42%	32
Candriam S.C.A.	Decreased	1M(-8.6%)	$33.4M	0.2%	-64.99%	0
Jefferies Financial Group Inc.	Increased	929,626(+5902.2%)	$31M	0.2%	—	56
NORTHERN TRUST CORP	Increased	920,314(+71.8%)	$30.7M	0.0%	-72.04%	43

ULTRAGENYX PHARMACEUTICAL IN

Smart Money Verdict

Who's Trading

Continue exploring

Other Healthcare stocks held by institutions

ULTRAGENYX PHARMACEUTICAL IN

Smart Money Verdict

Who's Trading

Top Holders

Continue exploring

Other Healthcare stocks held by institutions